1. Home
  2. FBIO vs KNW Comparison

FBIO vs KNW Comparison

Compare FBIO & KNW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FBIO
  • KNW
  • Stock Information
  • Founded
  • FBIO 2006
  • KNW 1998
  • Country
  • FBIO United States
  • KNW United States
  • Employees
  • FBIO N/A
  • KNW N/A
  • Industry
  • FBIO Biotechnology: Pharmaceutical Preparations
  • KNW Industrial Machinery/Components
  • Sector
  • FBIO Health Care
  • KNW Industrials
  • Exchange
  • FBIO Nasdaq
  • KNW Nasdaq
  • Market Cap
  • FBIO 48.2M
  • KNW 28.6M
  • IPO Year
  • FBIO N/A
  • KNW N/A
  • Fundamental
  • Price
  • FBIO $1.80
  • KNW $0.19
  • Analyst Decision
  • FBIO Strong Buy
  • KNW Buy
  • Analyst Count
  • FBIO 4
  • KNW 1
  • Target Price
  • FBIO $16.33
  • KNW $1.00
  • AVG Volume (30 Days)
  • FBIO 661.5K
  • KNW 413.8K
  • Earning Date
  • FBIO 11-12-2024
  • KNW 12-17-2024
  • Dividend Yield
  • FBIO N/A
  • KNW N/A
  • EPS Growth
  • FBIO N/A
  • KNW N/A
  • EPS
  • FBIO N/A
  • KNW N/A
  • Revenue
  • FBIO $82,624,000.00
  • KNW N/A
  • Revenue This Year
  • FBIO N/A
  • KNW N/A
  • Revenue Next Year
  • FBIO $81.63
  • KNW N/A
  • P/E Ratio
  • FBIO N/A
  • KNW N/A
  • Revenue Growth
  • FBIO 31.68
  • KNW N/A
  • 52 Week Low
  • FBIO $1.24
  • KNW $0.18
  • 52 Week High
  • FBIO $4.43
  • KNW $0.94
  • Technical
  • Relative Strength Index (RSI)
  • FBIO 61.24
  • KNW 27.41
  • Support Level
  • FBIO $1.50
  • KNW $0.18
  • Resistance Level
  • FBIO $1.65
  • KNW $0.23
  • Average True Range (ATR)
  • FBIO 0.09
  • KNW 0.02
  • MACD
  • FBIO 0.05
  • KNW -0.01
  • Stochastic Oscillator
  • FBIO 91.49
  • KNW 11.58

About FBIO Fortress Biotech Inc.

Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology, therapeutics sectors.

About KNW Know Labs Inc.

Know Labs Inc is a medical diagnostic. The company is focused on the development, marketing, and sales of proprietary technologies that are capable of uniquely identifying or authenticating almost any substance or material using electromagnetic energy to record, detect, and identify the signature of the substance or material known as Bio-RFID and ChromaID technologies. It is developing a wearable device that will measure blood glucose without fingersticks or microneedles.

Share on Social Networks: